{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:17:45Z","timestamp":1786465065379,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Frailty is a multidimensional syndrome associated with increased vulnerability to stressors, chronic disease exacerbations, hospitalizations, and disability. Polypharmacy, often defined as the chronic use of five or more medications, is closely and bidirectionally related to frailty. In this context, medication review is a potential strategy to improve health outcomes and slow down the frailty process by optimizing pharmacological treatments. This study aims to evaluate the impact of a geriatrician-led medication review, integrated within primary care (+\u2009AGIL Barcelona program) on polypharmacy and medication adequacy in older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated the effect of the\u2009+\u2009AGIL Barcelona program on medication adequacy. The\u2009+\u2009AGIL is a multidisciplinary and multicomponent intervention aimed at promoting healthy aging, based on a comprehensive geriatric assessment and a 10\u2013week structured exercise program, nutritional counseling, medication review, and healthy lifestyle promotion tailored to the individual's needs. Based on patient\u2019s frailty status, comorbidities, and preferences, geriatricians revised the medications, and the modifications were discussed with the participants\u2019 primary care physician, and in selected cases, with a clinical pharmacist. Baseline and three-month follow-up data were collected, including quantitative polypharmacy prevalence, and potentially inappropriate medications (PIMs), according to the EU(7)-PIM list. Subgroup analyses were based on Clinical Frailty Scale scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 173 community-dwelling older adults (mean age: 81.2\u00a0years \u2013 SD: 5.7; 68.8% women). At baseline, polypharmacy was prevalent (84.4%), with 59.5% of participants receiving at least one PIM. After three months, a slight reduction in the mean number of medications per patient was observed (7.6 to 7.4,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.051). Reduction of number of PIMs was also observed (1.0 to 0.9 per patient,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011), particularly in those medications affecting the nervous (from 30.1% to 24.3% in the sample,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025) and genitourinary (from 6.9% to 4.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.046) systems. After stratifying by frailty, a consistent trend was observed overall and especially among non-frail and vulnerable groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While the\u2009+\u2009AGIL Barcelona program had a limited quantitative impact on polypharmacy, it significantly reduced PIMs\u2019 use, particularly in nervous system-acting medications, which are involved in increased risk of falling and cognitive impairment in older adults. The study highlights the importance of medication review in multidimensional frailty management, although future research with larger samples and standardized medication review protocols is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-026-07699-x","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:37:09Z","timestamp":1780418229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of a complex intervention for older adults on medication adequacy: results from the\u2009+\u2009AGIL Barcelona program"],"prefix":"10.1186","volume":"26","author":[{"given":"Francesco","family":"Salis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"de Andr\u00e9s-L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Pamela","family":"Burbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Ignacio","family":"Soto-Bagaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"D\u00edaz-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Gual-Tarrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Inzitari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M\u00f3nica","family":"P\u00e9rez-Baz\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"1","key":"7699_CR1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1186\/s12877-023-04292-4","volume":"23","author":"C Arnal","year":"2023","unstructured":"Arnal C, P\u00e9rez LM, Soto L, Herrero \u00c1C, Ars J, Bar\u00f3 S, et al. Impact on physical function of the +AGIL Barcelona program in community-dwelling older adults with cognitive impairment: an interventional cohort study. BMC Geriatr. 2023;23(1):736. https:\/\/doi.org\/10.1186\/s12877-023-04292-4.","journal-title":"BMC Geriatr"},{"issue":"1","key":"7699_CR2","doi-asserted-by":"publisher","first-page":"CD008986","DOI":"10.1002\/14651858.CD008986.pub4","volume":"1","author":"C B\u00fclow","year":"2023","unstructured":"B\u00fclow C, Clausen SS, Lundh A, Christensen M. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2023;1(1):CD008986. https:\/\/doi.org\/10.1002\/14651858.CD008986.pub4. Accessed March 16, 2026.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"7699_CR3","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245\u201351. https:\/\/doi.org\/10.1016\/0895-4356(94)90129-5.","journal-title":"J Clin Epidemiol"},{"issue":"9868","key":"7699_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(12)62167-9. Epub 2013 Feb 8. Erratum in: Lancet. 2013;382(9901):1328.","journal-title":"Lancet"},{"key":"7699_CR5","doi-asserted-by":"publisher","unstructured":"Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, et al. Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis. BMC Geriatr. 2022;22(1):601. https:\/\/doi.org\/10.1186\/s12877-022-03279-x. Erratum in: BMC Geriatr. 2022;22(1):742. 10.1186\/s12877-022-03388-7","DOI":"10.1186\/s12877-022-03279-x"},{"issue":"10206","key":"7699_CR6","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(19)31785-4","volume":"394","author":"E Dent","year":"2019","unstructured":"Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet. 2019;394(10206):1376\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(19)31785-4.","journal-title":"Lancet"},{"issue":"7","key":"7699_CR7","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/bcp.13590","volume":"84","author":"M Guti\u00e9rrez-Valencia","year":"2018","unstructured":"Guti\u00e9rrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero \u00c1, Inzitari M, Mart\u00ednez-Velilla N. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol. 2018;84(7):1432\u201344. https:\/\/doi.org\/10.1111\/bcp.13590.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"7699_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.mayocp.2020.06.012","volume":"96","author":"RW Hoel","year":"2021","unstructured":"Hoel RW, Giddings Connolly RM, Takahashi PY. Polypharmacy management in older patients. Mayo Clin Proc. 2021;96(1):242\u201356. https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.012.","journal-title":"Mayo Clin Proc"},{"issue":"10206","key":"7699_CR9","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394(10206):1365\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(19)31786-6.","journal-title":"Lancet"},{"issue":"3","key":"7699_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00228-012-1387-2","volume":"69","author":"RE Hubbard","year":"2013","unstructured":"Hubbard RE, O\u2019Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol. 2013;69(3):319\u201326. https:\/\/doi.org\/10.1007\/s00228-012-1387-2.","journal-title":"Eur J Clin Pharmacol"},{"key":"7699_CR11","doi-asserted-by":"publisher","first-page":"e074892","DOI":"10.1136\/bmj-2023-074892","volume":"385","author":"A Hung","year":"2024","unstructured":"Hung A, Kim YH, Pavon JM. Deprescribing in older adults with polypharmacy. BMJ. 2024;385:e074892. https:\/\/doi.org\/10.1136\/bmj-2023-074892.","journal-title":"BMJ"},{"key":"7699_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejim.2018.07.022","volume":"56","author":"M Inzitari","year":"2018","unstructured":"Inzitari M, P\u00e9rez LM, Enfedaque MB, Soto L, D\u00edaz F, Gual N, et al. Integrated primary and geriatric care for frail older adults in the community: implementation of a complex intervention into real life. Eur J Intern Med. 2018;56:57\u201363. https:\/\/doi.org\/10.1016\/j.ejim.2018.07.022.","journal-title":"Eur J Intern Med"},{"issue":"9","key":"7699_CR13","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/gerona\/glac249","volume":"78","author":"H Jamieson","year":"2023","unstructured":"Jamieson H, Nishtala PS, Bergler HU, Weaver SK, Pickering JW, Ailabouni NJ, et al. Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2023;78(9):1692\u2013700. https:\/\/doi.org\/10.1093\/gerona\/glac249.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"7699_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1186\/s12877-023-04309-y","volume":"23","author":"AT Kolle","year":"2023","unstructured":"Kolle AT, Lewis KB, Lalonde M, Backman C. Reversing frailty in older adults: a scoping review. BMC Geriatr. 2023;23(1):751. https:\/\/doi.org\/10.1186\/s12877-023-04309-y.","journal-title":"BMC Geriatr"},{"issue":"20","key":"7699_CR15","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/j.jacc.2019.03.467","volume":"73","author":"A Krishnaswami","year":"2019","unstructured":"Krishnaswami A, Steinman MA, Goyal P, Zullo AR, Anderson TS, Birtcher KK, et al. Deprescribing in older adults with cardiovascular disease. J Am Coll Cardiol. 2019;73(20):2584\u201395. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.467.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"7699_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179\u201386.","journal-title":"Gerontologist"},{"issue":"2","key":"7699_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00228-020-02994-x","volume":"77","author":"A Lisibach","year":"2021","unstructured":"Lisibach A, Benelli V, Ceppi MG, Waldner-Knogler K, Csajka C, Lutters M. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review. Eur J Clin Pharmacol. 2021;77(2):147\u201362. https:\/\/doi.org\/10.1007\/s00228-020-02994-x.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"7699_CR18","doi-asserted-by":"publisher","first-page":"e0275456","DOI":"10.1371\/journal.pone.0275456","volume":"17","author":"A Lisowska","year":"2022","unstructured":"Lisowska A, Czepielewska E, Rydz M, Dworakowska A, Makarewicz-Wujec M, Koz\u0142owska-Wojciechowska M. Applicability of tools to identify potentially inappropriate prescribing in elderly during medication review: comparison of STOPP\/START version 2, Beers 2019, EU(7)-PIM list, PRISCUS list, and Amsterdam tool-a pilot study. PLoS ONE. 2022;17(9):e0275456. https:\/\/doi.org\/10.1371\/journal.pone.0275456.","journal-title":"PLoS ONE"},{"key":"7699_CR19","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61\u20135.","journal-title":"Md State Med J"},{"issue":"4","key":"7699_CR20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s11096-020-01206-x","volume":"43","author":"N Molist-Brunet","year":"2021","unstructured":"Molist-Brunet N, Sevilla-S\u00e1nchez D, Gonz\u00e1lez-Bueno J, Garcia-S\u00e1nchez V, Segura-Mart\u00edn LA, Codina-Jan\u00e9 C, et al. Therapeutic optimization through goal-oriented prescription in nursing homes. Int J Clin Pharm. 2021;43(4):990\u20137. https:\/\/doi.org\/10.1007\/s11096-020-01206-x.","journal-title":"Int J Clin Pharm"},{"issue":"11","key":"7699_CR21","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.amjmed.2015.06.017","volume":"128","author":"TP Ng","year":"2015","unstructured":"Ng TP, Feng L, Nyunt MS, Feng L, Niti M, Tan BY, et al. Nutritional, physical, cognitive, and combination interventions and frailty reversal among older adults: a randomized controlled trial. Am J Med. 2015;128(11):1225-1236.e1. https:\/\/doi.org\/10.1016\/j.amjmed.2015.06.017.","journal-title":"Am J Med"},{"issue":"3","key":"7699_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7861\/clinmedicine.14-3-292","volume":"14","author":"LM Pal","year":"2014","unstructured":"Pal LM, Manning L. Palliative care for frail older people. Clin Med. 2014;14(3):292\u20135. https:\/\/doi.org\/10.7861\/clinmedicine.14-3-292.","journal-title":"Clin Med"},{"issue":"1","key":"7699_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/ageing\/afx166","volume":"47","author":"SG Parker","year":"2018","unstructured":"Parker SG, McCue P, Phelps K, McCleod A, Arora S, Nockels K, et al. What is comprehensive geriatric assessment (CGA)? An umbrella review. Age Ageing. 2018;47(1):149\u201355. https:\/\/doi.org\/10.1093\/ageing\/afx166.","journal-title":"Age Ageing"},{"issue":"3","key":"7699_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","volume":"12","author":"F Pazan","year":"2021","unstructured":"Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12(3):443\u201352. https:\/\/doi.org\/10.1007\/s41999-021-00479-3.","journal-title":"Eur Geriatr Med"},{"issue":"8","key":"7699_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s12603-019-1244-4","volume":"23","author":"LM P\u00e9rez Baz\u00e1n","year":"2019","unstructured":"P\u00e9rez Baz\u00e1n LM, Enfedaque-Montes MB, Cesari M, Soto-Bagaria L, Gual N, Burbano MP, et al. A community program of integrated care for frail older adults: +AGIL Barcelona. J Nutr Health Aging. 2019;23(8):710\u20136. https:\/\/doi.org\/10.1007\/s12603-019-1244-4.","journal-title":"J Nutr Health Aging"},{"issue":"5","key":"7699_CR26","first-page":"339","volume":"64","author":"K Pottie","year":"2018","unstructured":"Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, et al. Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339\u201351.","journal-title":"Can Fam Physician"},{"issue":"8","key":"7699_CR27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s40266-022-00952-z","volume":"39","author":"MA Randles","year":"2022","unstructured":"Randles MA, O\u2019Mahony D, Gallagher PF. Frailty and potentially inappropriate prescribing in older people with polypharmacy: a bi-directional relationship? Drugs Aging. 2022;39(8):597\u2013606. https:\/\/doi.org\/10.1007\/s40266-022-00952-z.","journal-title":"Drugs Aging"},{"issue":"4","key":"7699_CR28","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/bcp.12386","volume":"78","author":"E Reeve","year":"2014","unstructured":"Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738\u201347. https:\/\/doi.org\/10.1111\/bcp.12386.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"7699_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489\u201395. https:\/\/doi.org\/10.1503\/cmaj.050051.","journal-title":"CMAJ"},{"issue":"10","key":"7699_CR30","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1016\/S2666-7568(23)00161-7","volume":"4","author":"WE Rosa","year":"2023","unstructured":"Rosa WE, Connor S, Ferrell BR, Fulmer T, Travers JL, Radbruch L. Palliation for the frail older adult and what meaningful longevity could be. Lancet Healthy Longev. 2023;4(10):e528\u201330. https:\/\/doi.org\/10.1016\/S2666-7568(23)00161-7.","journal-title":"Lancet Healthy Longev"},{"issue":"18","key":"7699_CR31","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.2018.16473","volume":"320","author":"MA Steinman","year":"2018","unstructured":"Steinman MA, Landefeld CS. Overcoming inertia to improve medication use and deprescribing. JAMA. 2018;320(18):1867\u20139. https:\/\/doi.org\/10.1001\/jama.2018.16473.","journal-title":"JAMA"},{"issue":"7","key":"7699_CR32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s12603-013-0363-6","volume":"17","author":"B Vellas","year":"2013","unstructured":"Vellas B, Balardy L, Gillette-Guyonnet S, Van Kan AG, Ghisolfi-Marque A, Subra J, et al. Looking for frailty in community-dwelling older persons: the Gerontopole Frailty Screening Tool (GFST). J Nutr Health Aging. 2013;17(7):629\u201331. https:\/\/doi.org\/10.1007\/s12603-013-0363-6.","journal-title":"J Nutr Health Aging"},{"issue":"9","key":"7699_CR33","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s40520-020-01559-3","volume":"32","author":"SJ Woolford","year":"2020","unstructured":"Woolford SJ, Sohan O, Dennison EM, Cooper C, Patel HP. Approaches to the diagnosis and prevention of frailty. Aging Clin Exp Res. 2020;32(9):1629\u201337. https:\/\/doi.org\/10.1007\/s40520-020-01559-3.","journal-title":"Aging Clin Exp Res"},{"key":"7699_CR34","volume-title":"Decade of healthy ageing: baseline report","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Decade of healthy ageing: baseline report. Geneva: WHO; 2020."},{"issue":"1","key":"7699_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12875-019-0953-4","volume":"20","author":"S Zechmann","year":"2019","unstructured":"Zechmann S, Trueb C, Valeri F, Streit S, Senn O, Neuner-Jehle S. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland. BMC Fam Pract. 2019;20(1):64. https:\/\/doi.org\/10.1186\/s12875-019-0953-4.","journal-title":"BMC Fam Pract"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-07699-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07699-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07699-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:03:25Z","timestamp":1786457005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-07699-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7699"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-07699-x","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The\u2009+\u2009AGIL Barcelona program and the present analysis were conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent prior to participation. Ethical approval was obtained as a part of the original program evaluation by the Clinical Research Ethics Committee of the University Institute for Primary Care Research, Jordi Gol i Gorina Foundation, Catalan Institute of Health (P18\/019).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1024"}}